NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CEO George Lawrence Mikan III sold 31,798 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $233,079.34. Following the transaction, the chief executive officer now directly owns 146,539 shares of the company’s stock, valued at approximately $1,074,130.87. This represents a 17.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
George Lawrence Mikan III also recently made the following trade(s):
- On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total value of $70,236.54.
NeueHealth Stock Performance
NEUE stock opened at $7.45 on Thursday. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59. The firm has a market cap of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57. The stock’s 50 day moving average price is $5.51 and its 200 day moving average price is $5.39.
Analyst Upgrades and Downgrades
View Our Latest Report on NeueHealth
Institutional Trading of NeueHealth
A number of large investors have recently made changes to their positions in the stock. NEA Management Company LLC acquired a new position in NeueHealth in the 2nd quarter valued at about $14,834,000. Deer Management Co. LLC purchased a new stake in shares of NeueHealth during the second quarter worth about $5,436,000. Partners Group Holding AG purchased a new position in shares of NeueHealth during the third quarter valued at approximately $463,000. Finally, Renaissance Technologies LLC acquired a new stake in NeueHealth during the second quarter worth approximately $312,000. Institutional investors and hedge funds own 63.88% of the company’s stock.
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- How is Compound Interest Calculated?
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
- What does consumer price index measure?
- Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.